Self-efficacy and hemoglobin A1C among adults with serious mental illness and type 2 diabetes: The roles of cognitive functioning and psychiatric symptom severity

Psychosomatic Medicine

Volumn 78, Issue 3, 2016, Pages 263-270

  Wykes, Thomas L ^a   Lee, Aaron A ^a   McKibbin, Christine L ^a   Laurent, Sean M ^b  

^a UNIVERSITY OF WYOMING   (United States)

^b UNIVERSITY OF OREGON   (United States)

Author keywords

Diabetes mellitus; Diabetes self efficacy; Glycemic control; Serious mental illness

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; BIPOLAR DISORDER; COGNITION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; POSITIVE SYNDROME; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SELF CONCEPT; BLOOD; COGNITIVE DYSFUNCTION; COMORBIDITY; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; PSYCHOTIC DISORDERS; SELF CARE;

BIPOLAR DISORDER; COGNITIVE DYSFUNCTION; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SELF CARE; SELF EFFICACY;

EID: 84963630997     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000295     Document Type: Article

References (58)

1. Anderson RM, Fitzgerald JT, Oh M. The relationship between diabetes-related attitudes and patients' self-reported adherence. Diabetes Educ 1993;19:287-92.
2. Haas L, Maryniuk M, Beck J, Cox CE, Duker P, Edwards L, Fisher EB, Hanson L, Kent D, Kolb L, McLaughlin S, Orzeck E, Piette JD, Rhinehart AS, Rothman R, Sklaroff S, Tomky D, Youssef G, 2012 Standards Revision Task Force. National standards for diabetes self-management education and support. Diabetes Care 2014;37(suppl 1):S144-53.
3. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014;37(suppl 1):S14-79.
4. Funnell MM, Tang TS, Anderson RM. From DSME to DSMS: developing empowerment-based diabetes self-management support. Diabetes Spectr 2007;20:221-6.
5. Anderson RM, Funnell MM, Fitzgerald JT, Marrero DG. The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy. Diabetes Care 2000;23:739-43.
6. Hurley AC, Shea CA. Self-efficacy: strategy for enhancing diabetes self-care. Diabetes Educ 1992;18:146-50.
7. Krichbaum K, Aarestad V, Buethe M. Exploring the connection between self-efficacy and effective diabetes selfmanagement. Diabetes Educ 2003;29:653-62.
8. King DK, Glasgow RE, Toobert DJ, Strycker LA, Estabrooks PA, Osuna D, Faber AJ. Self-efficacy, problem solving, and social-environmental support are associated with diabetes self-management behaviors. Diabetes Care 2010;33:751-3.
9. Aljasem LI, Peyrot M, Wissow L, Rubin RR. The impact of barriers and self-efficacy on self-care behaviors in Type 2 diabetes. Diabetes Educ 2001;27:393-404.
10. Gherman A, Schnur J, Montgomery G, Sassu R, Veresiu I, David D. How are adherent people more likely to think? A meta-analysis of health beliefs and diabetes self-care. Diabetes Educ 2011;37:392-408.
11. Trief PM, Teresi JA, Eimicke JP, Shea S, Weinstock RS. Improvement in diabetes self-efficacy and glycaemic control using telemedicine in a sample of older, ethnically diverse individuals who have diabetes: the IDEATel project. Age Ageing 2009;38:219-25.
12. Susce MT, Villanueva N, Diaz FJ, de Leon J. Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. J Clin Psychiatry 2005;66:167-73.
13. Dixon L, Weiden P, Delahanty J, Goldberg R, Postrado L, Lucksted A, Lehman A. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 2000;26:903-12.
14. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects. CNS Drugs 2005;19:1-93.
15. Cimo A, Stergiopoulos E, Cheng C, Bonato S, Dewa CS. Effective lifestyle interventions to improve type II diabetes self-management for those with schizophrenia or schizoaffective disorder: a systematic review. BMC Psychiatry 2012;12:1-9.
16. Goldberg R, Kreyenbuhl J, Medoff D, Dickerson F, Wohlheiter K, Fang LJ, Brown CH, Dixon LB. Quality of diabetes care among adults with serious mental illness. Psychiatr Serv 2007;58:536-43.
17. Dixon LB, Kreyenbuhl JA, Dickerson FB, Donner TW, Brown CH, Wolheiter K, Postrado L, Goldberg RW, Fang L, Marano C, Messias E. A comparison of Type 2 diabetes outcomes among persons with and without severe mental illnesses. Psychiatr Serv 2004;55:892-900.
18. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Chronic illness with complexities: mental illness and substance use among veteran clinic users with diabetes. Am J Drug Alcohol Abuse 2007;33:807-21.
19. Becker T, Hux J. Risk of acute complications of diabetes among people with schizophrenia in Ontario, Canada. Diabetes Care 2011;34:398-402.
20. Dickerson F, Brown CH, Fang L, Goldberg RW, Kreyenbuhl J, Wohlheiter K, Dixon L. Quality of life in individuals with serious mental illness and Type 2 diabetes. Psychosomatics 2008;49:109-14.
21. Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007;116:317-33.
22. Vancampfort D, Vansteelandt K, Correll CU, Mitchell AJ, De Herdt A, Sienaert P, Probst M, De Hert M. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry 2013;170:265-74.
23. Gutierrez J, Long JA. Reliability and validity of diabetes specific Health Beliefs Model scales in patients with diabetes and serious mental illness. Diabetes Res Clin Pract 2011;92:342-7.
24. Leutwyler HC, Wallhagen M, McKibbin C. The impact of symptomatology on response to a health promoting intervention among older adults with schizophrenia. Diabetes Educ 2010;36:945-55.
25. Pratt SI, Mueser KT, Smith TE, Lu W. Self-efficacy and psychosocial functioning in schizophrenia: a mediational analysis. Schizophr Res 2005;78:187-97.
26. El-Mallakh P. Evolving self-care in individuals with schizophrenia and diabetes mellitus. Arch Psychiatr Nurs 2006;20:55-64.
27. Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry 2007;64:532-42.
28. Mann-Wrobel MC, Carreno JT, Dickinson D. Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. Bipolar Disord 2011;13:334-42.
29. Reijmer YD, van den Berg E, Ruis C, Jaap Kappelle L, Biessels GJ. Cognitive dysfunction in patients with Type 2 diabetes. Diabetes Metab Res Rev 2010;26:507-19.
30. Dickinson D, Gold JM, Dickerson FB, Medoff D, Dixon LB. Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes. Psychosomatics 2008;49:123-31.
31. Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S, Jeste DV. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr Res 2003;63:49-58.
32. Primožič S, Tavčar R, Avbelj M, Dernovšek MZ, Oblak MR. Specific cognitive abilities are associated with diabetes selfmanagement behavior among patients with Type 2 diabetes. Diabetes Res Clin Pract 2012;95:48-54.
33. Teachout A, Kaiser SM, Wilkniss SM, Moore H. Paxton House: integrating mental health and diabetes care for people with serious mental illnesses in a residential setting. Psychiatr Rehabil J 2011;34:324-7.
34. Kay SR, Flszbein A, Opfer LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76.
35. Kay SR, Opler LA, Lindenmayer JP Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 1988;23:99-110.
36. Jurica P, Leitten C, Mattis S. Dementia Rating Scale 2: Professional Manual. Odessa, FL: Psychological Assessment Resources Inc.; 2001.
37. Smith GE, Ivnik RJ, Malec JF, Kokmen E, Tangalos E, Petersen RC. Psychometric properties of the Mattis Dementia Rating Scale. Assessment 1994;1:123-31.
38. Sitzer DI, Twamley EW, Patterson TL, Jeste DV. Multivariate predictors of social skills performance in middle-aged and older out-patients with schizophrenia spectrum disorders. Psychol Med 2008;38:755-64.
39. Ellis G, Diamandis EP, Giesbrecht EE, Daneman D, Allen L. An automated "high-pressure" liquid-chromatographic assay for hemoglobin A1C. Clin Chem 1984;30:1746-52.
40. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.
41. Rubin RR, Peyrot M, Saudek CD. The effect of a diabetes education program incorporating coping skills training on emotional well-being and diabetes self-efficacy. Diabetes Educ 1993;19:210-4.
42. Bruce DG, Davis WA, Cull CA, Davis TM. Diabetes education and knowledge in patients with Type 2 diabetes from the community: the Fremantle Diabetes Study. J Diabetes Complications 2003;17:82-9.
43. Aiken LS, West SG Multiple Regression: Testing and Interpreting Interactions. Thousand Oaks: Sage; 1991.
44. Preacher KJ, Curran PJ, Bauer DJ. Computational tools for probing interactions in multiple linear regression, multilevel modeling, and latent curve analysis. J Educ Behav Stat 2006;31:437-48.
45. Corp I. IBM SPSS Statistics for Windows. 21.0 ed. Armonk, NY: IMB Corp; Released; 2012.
46. Howard R, Rabins PV, Seeman MV, Jeste DV. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. Am J Psychiatry 2000;157:172-8.
47. Lucas JA, Ivnik RJ, Smith GE, Bohac DL, Tangalos EG, Kokmen E, Graff-Radford NR, Petersen RC. Normative data for the Mattis Dementia Rating Scale. J Clin Exp Neuropsychol 1998;20:536-47.
48. Eyler Zorrilla LT, Heaton RK, McAdams LA, Zisook S, Harris MJ, Jeste DV. Cross-sectional study of older outpatients with schizophrenia and healthy comparison subjects: no differences in age-related cognitive decline. Am J Psychiatry 2000;157:1324-6.
49. Savla GN, Moore DJ, Roesch SC, Heaton RK, Jeste DV, Palmer BW. An evaluation of longitudinal neurocognitive performance among middle-aged and older schizophrenia patients: use of mixed-model analyses. Schizophr Res 2006;83:215-23.
50. Anderson RM, Funnell MM, Nwankwo R, Gillard ML, Oh M, Fitzgerald JT. Evaluating a problem-based empowerment program for African Americans with diabetes: results of a randomized controlled trial. Ethn Dis 2005;15:671-8.
51. Dickerson FB, Goldberg RW, Brown CH, Kreyenbuhl JA, Wohlheiter K, Fang L, Medoff D, Dixon LB. Diabetes knowledge among persons with serious mental illness and Type 2 diabetes. Psychosomatics 2005;46:418-24.
52. Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP, Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 2009;70(suppl 4):1-46.
53. McAndrew LM, Horowitz CR, Lancaster KJ, Leventhal H. Factors related to perceived diabetes control are not related to actual glucose control for minority patients with diabetes. Diabetes Care 2010;33:736-8.
54. Kreyenbuhl J, Dixon LB, McCarthy JF, Soliman S, Ignacio RV, Valenstein M. Does adherence to medications for Type 2 diabetes differ between individuals with vs without schizophrenia? Schizophr Bull 2010;36:428-35.
55. Velligan D, Mintz J, Maples N, Xueying L, Gajewski S, Carr H, Sierra C. A randomized trial comparing in person and electronic interventions for improving adherence to oral medications in schizophrenia. Schizophr Bull 2013;39:999-1007.
56. Rathod S, Kingdon D, Smith P, Turkington D. Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics-data on a previously published randomised controlled trial. Schizophr Res 2005;74:211-9.
57. Bowie CR, McGurk SR, Mausbach B, Patterson TL, Harvey PD. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. Am J Psychiatry 2012;169:710-8.
58. Collins LM, Nahum-Shani I, Almirall D. Optimization of behavioral dynamic treatment regimens based on the sequential, multiple assignment, randomized trial (SMART). Clin Trials 2014;11:426-34.